Remed Co.,Ltd. (KOSDAQ:302550)
2,245.00
-30.00 (-1.32%)
At close: Oct 23, 2026
Remed Revenue
Remed had revenue of 7.37B KRW in the quarter ending June 30, 2026, with 32.68% growth. This brings the company's total for the last twelve months to 27.05B, up 10.52% year-over-year. In the year 2025, Remed had annual revenue of 24.50B, down -4.11%. That makes Remed the 33,693rd largest company in the world by revenue and 2,151st in South Korea.
Revenue (ttm)
27.05B
Revenue Growth
+10.52%
P/S Ratio
2.47
Revenue / Employee
307.41M
Employees
88
Market Cap
66.80B
Revenue by Geography
- Europe 9.39B 38.3%
- South Korea 6.88B 28.1%
- Other 6.80B 27.8%
- Japan 1.34B 5.5%
- China 97.37M 0.4%
Fiscal year ended Dec 31, 2025 See the full Remed breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.50B | -1.05B | -4.11% |
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 109.45B |
| Genoray | 107.88B |
| JPI Healthcare | 46.86B |
| L&K Biomed | 39.94B |
| Hironic | 37.10B |
| SELVAS Healthcare | 31.69B |
| Dynamic solution | 15.11B |
| QuantaMatrix | 3.15B |